Advertisement

Topics

Amicus Therapeutics receives U.S. approval for Fabry disease drug

12:50 EDT 10 Aug 2018 | Reuters

U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.

Original Article: Amicus Therapeutics receives U.S. approval for Fabry disease drug

NEXT ARTICLE

More From BioPortfolio on "Amicus Therapeutics receives U.S. approval for Fabry disease drug"

Advertisement
Quick Search
Advertisement
Advertisement